Acebutolol metabolite plasma concentration during chronic oral therapy. 1977

R A Winkle, and P J Meffin, and W B Ricks, and D C Harrison

1 We have measured the plasma concentration of acebutolol and a major metabolite in patients on chronic oral therapy with this drug, using a new assay, specific for each species. Our study suggests: 2 The acetyl metabolite was present in concentrations greater than those of acebutolol at all times during the dosing interval in all seven subjects. 3 The ratio of the mean steady-state plasma concentrations of the acetyl metabolite to unchanged acebutolol was 2.7 +/- 1.0. 4 Previous studies using non-specific methods that measure plasma concentrations of the acetyl metabolite and acebutolol as a single species cannot be used to determine pharmacokinetic parameters or to provide reliable correlations of plasma drug concentration with effect. 5 Future studies determining plasma concentration of acebutolol should take this metabolite into account. 6 Further work will be necessary to determine the metabolite's contribution to acebutolol's effects in man.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000070 Acebutolol A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action. Acebutolol Hydrochloride,Acetobutolol,Apo-Acebutolol,M & B 17803A,M&B-17803 A,Monitan,Neptal,Novo-Acebutolol,Prent,Rhotral,Sectral,Apo Acebutolol,ApoAcebutolol,M&B 17803 A,M&B17803 A,Novo Acebutolol,NovoAcebutolol
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D001145 Arrhythmias, Cardiac Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. Arrhythmia,Arrythmia,Cardiac Arrhythmia,Cardiac Arrhythmias,Cardiac Dysrhythmia,Arrhythmia, Cardiac,Dysrhythmia, Cardiac
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

R A Winkle, and P J Meffin, and W B Ricks, and D C Harrison
January 1984, Hypertension (Dallas, Tex. : 1979),
R A Winkle, and P J Meffin, and W B Ricks, and D C Harrison
April 1990, Cardiovascular drugs and therapy,
R A Winkle, and P J Meffin, and W B Ricks, and D C Harrison
May 1979, La Nouvelle presse medicale,
R A Winkle, and P J Meffin, and W B Ricks, and D C Harrison
March 1985, Annals of the Royal College of Surgeons of England,
R A Winkle, and P J Meffin, and W B Ricks, and D C Harrison
January 1978, International pharmacopsychiatry,
R A Winkle, and P J Meffin, and W B Ricks, and D C Harrison
June 1979, Clinical pharmacology and therapeutics,
R A Winkle, and P J Meffin, and W B Ricks, and D C Harrison
September 1987, Revista medica de Chile,
R A Winkle, and P J Meffin, and W B Ricks, and D C Harrison
June 1973, Lancet (London, England),
R A Winkle, and P J Meffin, and W B Ricks, and D C Harrison
August 1979, British journal of clinical pharmacology,
Copied contents to your clipboard!